APP
TBIO

Alpha Paradigm Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Alpha Paradigm Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,393
Closed -$831K – 731
2021
Q1 		$831K Buy
+50,393
New +$1.15M 0.32% 88

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alpha Paradigm Partners's TBIO Position: Q2 2021 in Review

Alpha Paradigm Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 50,393 shares — an estimated $831K sold.

Alpha Paradigm Partners first reported a position in TBIO in Q1 2021 and held it in 1 quarter. The position peaked at $831K in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Alpha Paradigm Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Alpha Paradigm Partners sold 50,393 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $831K.
  • Alpha Paradigm Partners first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Alpha Paradigm Partners's Translate Bio, Inc. Common Stock position peaked at $831K in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Alpha Paradigm Partners's 13F filing for Q2 2021, filed 13 Aug 2021.